BEQVEZ
Biological
PFIZER INC.
Total Payments
$347,235
Transactions
54
Doctors
35
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $347,235 | 54 | 35 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $320,875 | 8 | 92.4% |
| Consulting Fee | $20,750 | 10 | 6.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,718 | 6 | 1.4% |
| Food and Beverage | $891.67 | 30 | 0.3% |
Payments by Type
Research
$320,875
8 transactions
General
$26,359
46 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| GENE THERAPY IN NEONATAL HEMOPHILIA B PUPPIES | PFIZER INC. | $265,197 | 0 |
| JUVENILE HEMOPHILIA B DOG STUDY | PFIZER INC. | $55,179 | 0 |
| THE DETERMINATION OF FIX C LEVELS IN HUMAN PLASMA SAMPLES FROM PATIENTS TREATED WITH FIDANACOGENE ELAPARVOVEC | PFIZER INC. | $500.00 | 0 |
Top Doctors Receiving Payments for BEQVEZ — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , FNP | Family | Emeryville, CA | $26.23 | 1 |
| , M.D | Pediatric Hematology-Oncology | Madera, CA | $26.23 | 1 |
| , MD | Pediatric Hematology-Oncology | Orange, CA | $25.29 | 1 |
| , M.D | Hematology | Pittsburgh, PA | $21.87 | 2 |
| , DO | Student in an Organized Health Care Education/Training Program | Pittsburgh, PA | $20.20 | 1 |
| , M.D | Pediatrics | Pittsburgh, PA | $20.20 | 1 |
| , MD | Pediatric Hematology-Oncology | Las Vegas, NV | $19.56 | 1 |
| , APRN | Registered Nurse | Las Vegas, NV | $19.56 | 1 |
| , DO | Pediatric Hematology-Oncology | Orange, CA | $19.56 | 1 |
| , MD | Pediatric Hematology-Oncology | Atlanta, GA | $7.82 | 1 |
| , MD | Hematology & Oncology | Augusta, GA | $5.62 | 1 |
Ad
Manufacturing Companies
- PFIZER INC. $347,235
Product Information
- Type Biological
- Total Payments $347,235
- Total Doctors 35
- Transactions 54
About BEQVEZ
BEQVEZ is a biological associated with $347,235 in payments to 35 healthcare providers, recorded across 54 transactions in the CMS Open Payments database. The primary manufacturer is PFIZER INC..
Payment data is available from 2024 to 2024. In 2024, $347,235 was paid across 54 transactions to 35 doctors.
The most common payment nature for BEQVEZ is "Unspecified" ($320,875, 92.4% of total).
BEQVEZ is associated with 3 research studies, including "GENE THERAPY IN NEONATAL HEMOPHILIA B PUPPIES" ($265,197).